Amyloidosis Global Clinical Trials Research 2024 globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
InsightAce Analytic Pvt. Ltd: High Potency Drug Market worth USD 379.20 Billion by 2031 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement - Takeda Pharmaceutical (NYSE:TAK) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Hutchmed Ltd on Friday said that its partner Takeda Pharmaceutical Co Ltd has been notified that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommends.
Hutchmed notes CHMP's positive opinion for fruiquintinib approval lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Research and Markets: Hemophilia a (Factor Viii Deficiency) Global Clinical Trials Review 2024: Trial Status, Trial Phase, Sponsor Type and End Point Status finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pharma perfect match for China's new forces chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Hutchmed Ltd - Hong Kong-based developer of treatments.